KIDNEY TRANSPLANT REJECTION
Clinical trials for KIDNEY TRANSPLANT REJECTION explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT REJECTION trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT REJECTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New drug combo aims to stop kidney rejection in its tracks
Disease control Not yet recruitingThis study tests whether adding two drugs, carfilzomib and belatacept, to standard care can safely improve kidney function in transplant patients whose bodies are making antibodies that attack the new kidney. About 25 adults who had a kidney transplant at least 6 months ago will …
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) • Aim: Disease control
Last updated May 01, 2026 15:59 UTC
-
Stem cell therapy fails to help kidney rejection, raises safety flags
Disease control Not yet recruitingThis study tested whether a patient's own stem cells (MSCs) could help treat chronic antibody-mediated rejection in kidney transplant recipients. Only 3 patients were treated before the study was stopped early due to serious side effects. The stem cells did not improve rejection,…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: Shahid Beheshti University of Medical Sciences • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
AI takes on kidney transplant rejection: smarter dosing could save organs
Disease control Not yet recruitingThis pilot study tests whether an AI-based system can help doctors choose the right doses of immunosuppressive drugs for kidney transplant patients. The goal is to reduce kidney scarring and protect organ function over time. About 34 adult kidney transplant recipients will take p…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: NA • Sponsor: University of Florida • Aim: Disease control
Last updated May 01, 2026 15:57 UTC
-
New drug could unlock donor kidneys for hard-to-match patients
Disease control Not yet recruitingThis study tests whether belimumab, a drug that affects immune cells, can improve detection of antibodies that make it hard for some kidney patients to find a donor. About 25 highly sensitized adults waiting for a kidney transplant will receive a short course of belimumab. Resear…
Matched conditions: KIDNEY TRANSPLANT REJECTION
Phase: PHASE2 • Sponsor: Leiden University Medical Center • Aim: Disease control
Last updated Apr 29, 2026 15:01 UTC